Bonnie L. Bassler

Insider Reports History

Location
Tarrytown, NY
Signature
/s/ Bonnie L. Bassler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bonnie L. Bassler:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc Director Class A Ordinary Shares 73,132 $2,833,265 $38.74 31 Dec 2025 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 1,703 $1,362,400 $800.00 07 Jan 2026 Direct
Cidara Therapeutics, Inc. Director Common Stock 0 $0 $221.50 07 Jan 2026 Direct
Kaleido Biosciences, Inc. Director Stock Option (Right to Buy) 15,000 30 Jun 2021 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 2,861 07 Jan 2026 Direct
Cidara Therapeutics, Inc. Director Stock Option (right to buy) 0 07 Jan 2026 Direct

Insider Reports Filed by Bonnie L. Bassler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REGN REGENERON PHARMACEUTICALS, INC. 07 Jan 2026 3 -$638,820 4 Director 08 Jan 2026, 16:03
CDTX Cidara Therapeutics, Inc. 07 Jan 2026 8 -$3,322 4 Director 07 Jan 2026, 20:19
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 16:08
RPRX Royalty Pharma plc 31 Dec 2025 1 +$37,463 4 Director 02 Jan 2026, 16:06
REGN REGENERON PHARMACEUTICALS, INC. 20 Nov 2025 3 -$287,736 4 Director 24 Nov 2025, 16:05
RPRX Royalty Pharma plc 30 Sep 2025 1 +$37,469 4 Director 30 Sep 2025, 16:54
RPRX Royalty Pharma plc 30 Jun 2025 1 +$37,495 4 Director 30 Jun 2025, 17:04
CDTX Cidara Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 18 Jun 2025, 17:03
RPRX Royalty Pharma plc 13 May 2025 1 $0 4 Director 14 May 2025, 17:04
RPRX Royalty Pharma plc 31 Mar 2025 1 +$37,500 4 Director 01 Apr 2025, 17:46
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 16:04
RPRX Royalty Pharma plc 31 Dec 2024 1 +$37,487 4 Director 02 Jan 2025, 16:29
CDTX Cidara Therapeutics, Inc. 17 Dec 2024 1 $0 4 Director 19 Dec 2024, 18:17
RPRX Royalty Pharma plc 30 Sep 2024 1 +$37,475 4 Director 30 Sep 2024, 17:08
REGN REGENERON PHARMACEUTICALS, INC. 15 Aug 2024 3 -$603,742 4 Director 19 Aug 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 02 Aug 2024 3 -$562,162 4 Director 05 Aug 2024, 16:05
CDTX Cidara Therapeutics, Inc. 18 Jul 2024 1 $0 4 Director 19 Jul 2024, 16:55
RPRX Royalty Pharma plc 28 Jun 2024 1 +$37,493 4 Director 28 Jun 2024, 17:09
REGN REGENERON PHARMACEUTICALS, INC. 24 Jun 2024 3 -$522,094 4 Director 25 Jun 2024, 16:41
RPRX Royalty Pharma plc 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:09
REGN REGENERON PHARMACEUTICALS, INC. 05 Jun 2024 3 -$521,051 4 Director 07 Jun 2024, 16:06
RPRX Royalty Pharma plc 28 Mar 2024 1 +$37,483 4 Director 02 Apr 2024, 17:28
REGN REGENERON PHARMACEUTICALS, INC. 26 Feb 2024 3 -$501,580 4 Director 26 Feb 2024, 16:07
REGN REGENERON PHARMACEUTICALS, INC. 30 Jan 2024 3 -$478,047 4 Director 31 Jan 2024, 16:52
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2024 5 -$440,299 4 Director 04 Jan 2024, 16:11
RPRX Royalty Pharma plc 29 Dec 2023 1 +$37,493 4 Director 29 Dec 2023, 17:11
REGN REGENERON PHARMACEUTICALS, INC. 13 Dec 2023 3 -$300,919 4 Director 14 Dec 2023, 16:07
RPRX Royalty Pharma plc 29 Sep 2023 1 +$37,475 4 Director 03 Oct 2023, 16:23
REGN REGENERON PHARMACEUTICALS, INC. 21 Aug 2023 3 -$372,829 4 Director 23 Aug 2023, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 10 Aug 2023 3 -$338,709 4 Director 11 Aug 2023, 16:13
RPRX Royalty Pharma plc 30 Jun 2023 1 +$37,481 4 Director 30 Jun 2023, 09:12
RPRX Royalty Pharma plc 23 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:02
CDTX Cidara Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 17:17
RPRX Royalty Pharma plc 31 Mar 2023 1 +$37,478 4 Director 31 Mar 2023, 16:38
REGN REGENERON PHARMACEUTICALS, INC. 24 Mar 2023 3 -$541,942 4 Director 27 Mar 2023, 16:43
REGN REGENERON PHARMACEUTICALS, INC. 03 Feb 2023 3 -$406,409 4 Director 07 Feb 2023, 15:09
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2023 2 $0 4 Director 05 Jan 2023, 15:21
RPRX Royalty Pharma plc 30 Dec 2022 1 +$37,495 4 Director 03 Jan 2023, 16:09
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2022 3 -$86,775 4 Director 12 Dec 2022, 15:35
RPRX Royalty Pharma plc 30 Sep 2022 1 +$37,490 4 Director 30 Sep 2022, 16:29
REGN REGENERON PHARMACEUTICALS, INC. 08 Sep 2022 9 -$999,689 4 Director 12 Sep 2022, 16:31
RPRX Royalty Pharma plc 30 Jun 2022 1 +$37,493 4 Director 30 Jun 2022, 06:55
RPRX Royalty Pharma plc 24 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:57
CDTX Cidara Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 17:31
REGN REGENERON PHARMACEUTICALS, INC. 07 Apr 2022 3 -$426,622 4 Director 11 Apr 2022, 16:38
RPRX Royalty Pharma plc 31 Mar 2022 1 +$37,471 4 Director 01 Apr 2022, 18:26
REGN REGENERON PHARMACEUTICALS, INC. 30 Mar 2022 3 -$395,622 4 Director 01 Apr 2022, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2022 2 $0 4 Director 05 Jan 2022, 15:22
RPRX Royalty Pharma plc 31 Dec 2021 1 +$37,463 4 Director 03 Jan 2022, 16:29
RPRX Royalty Pharma plc 30 Sep 2021 1 +$37,499 4 Director 30 Sep 2021, 15:12
REGN REGENERON PHARMACEUTICALS, INC. 16 Aug 2021 3 -$308,785 4 Director 17 Aug 2021, 16:16
REGN REGENERON PHARMACEUTICALS, INC. 05 Aug 2021 3 -$532,477 4 Director 06 Aug 2021, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 01 Jul 2021 3 -$468,319 4 Director 02 Jul 2021, 16:01
/report/000120919121044435-bassler-bonnie-l-2021-06-30 Kaleido Biosciences, Inc. 30 Jun 2021 1 $0 4 Director 01 Jul 2021, 16:38
RPRX Royalty Pharma plc 30 Jun 2021 1 +$37,489 4 Director 30 Jun 2021, 17:15
RPRX Royalty Pharma plc 25 Jun 2021 1 $0 4 Director 29 Jun 2021, 20:30
CDTX Cidara Therapeutics, Inc. 23 Jun 2021 1 $0 4 Director 24 Jun 2021, 17:53